Thiazole-based nitric oxide donors having alkyl...

Details Thiazole-based nitric oxide donors having alkyl... Thiazole-based nitric oxide donors having alkyl...

2005-11-04

2009-08-25

Stockton, Laura L. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S365000

Reexamination Certificate

active

07579477

ABSTRACT:
Disclosed are novel NO-donating compounds, designed such that when NO is released from the compound a residue which is a naturally occurring metabolite is formed, and thus a development of tolerance to the compounds upon repetitive administration is prevented or decreased. Also disclosed are methods of preparing such NO-donating compounds, pharmaceutical compositions and medical devices containing such compounds and methods utilizing such compounds in the treatment of various medical conditions.

REFERENCES:
patent: 4505857 (1985-03-01), Egli
patent: 4923886 (1990-05-01), Shiokawa et al.
patent: 5404871 (1995-04-01), Goodman et al.
patent: 5542410 (1996-08-01), Goodman et al.
patent: 5807847 (1998-09-01), Thatcher et al.
patent: 5874063 (1999-02-01), Briggner et al.
patent: 5883122 (1999-03-01), Thatcher et al.
patent: 5983956 (1999-11-01), Trofast
patent: 6221398 (2001-04-01), Jakupovic et al.
patent: 6268533 (2001-07-01), Gao et al.
patent: 6310052 (2001-10-01), Thatcher et al.
patent: 6552047 (2003-04-01), Garvey et al.
patent: 6566324 (2003-05-01), Nadel et al.
patent: 6571790 (2003-06-01), Weinstein
patent: 6637430 (2003-10-01), Voges et al.
patent: 6652323 (2003-11-01), Yanda
patent: 6916835 (2005-07-01), Thatcher et al.
patent: 7189750 (2007-03-01), Assaf et al.
patent: 2002/0177622 (2002-11-01), Thatcher et al.
patent: 2005/0137191 (2005-06-01), Thatcher et al.
patent: 2007/0021382 (2007-01-01), Assaf et al.
patent: 452782 (1991-10-01), None
patent: WO 99/55319 (1999-04-01), None
patent: WO 00/30614 (2000-02-01), None
patent: WO 01/49275 (2001-07-01), None
patent: WO 03/086282 (2003-10-01), None
Golub et al., Science, vol. 286, Oct. 15, 1999, pp. 531-537.
U.S. Appl. No. 09/473,713, filed Dec. 29, 1999, Thatcher et al.
Kumar et al. “Design, Synthesis, and Evaluation of α-Ketoheterocycles as Class C β- Lactamase Inhibitors”, Bioorganic & Medicinal Chemistry, 9: 2035-2044, 2001.
Cavicchi et al. “Inhibition of Inducible Nitric Oxide Synthase in the Human Intestinal Epithelial Cell Line, DLD-1, by the Inducers of Heme Oxygenase 1, Bismuth Salts, Heme, and Nitric Oxide Donors”, GUT, 47(6): 771-778, 2000. Abstract.
Salas et al. “Nitric Oxide Supplementation Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice”, Laboratory Investigation, 82(5): 597-607, 2002. Abstract, p. 602, col. 1, Lines 3-19.
Ueda et al. “Structure-Activity Relationships of 2-Aminothiazole Derivatives as Inducible Nitric Oxide Synthase Inhibitor”, Chemical & Pharmaceutical Bulletin, 52(5): 634-637, 2004. Abstract, p. 634, col. 2, Last Line—p. 635, col. 1, Line 2, Table 2, Expls. 5a, 5b, 7, p. 636, col. 1, Lines 17-18, 25-39.
Münzel et al. “Evidence fpr Enhanced Vascular Superpxide Anion Production”, The Journal of Clinical Investigation, 95: 187-194, 1995.
Chung et al. Identification of the Subcellular Site for Nitroglycerin Metabolism to Nitric Oxide in Bovine Coronary Smoth Muscle Cells, The Journal of Pharmacology and Experimental Therapeautics, 253(2): 614-619, 1990.
McGuire et al. “Inhibition of NADPH-Cytochrome P450 Reductase and Glyceryl Trinitrate Biotransformation by Diphenyleneidononium Sulfate”, Biochemical Pharmacology, 56: 881-893, 1998.
Needleman et al. “Sulfhydryl Requirement for Relaxation of Vascular Smooth Muscle”, The Journal of Pharmacology and Experimental Therapeutics, 187(2): 324-331, 1973.
Bueb et al. “Natural Polyamines Stimulate G-Proteins”, Biochemical Journal, 282: 545-550, 1992.
Loscalzo “N-Acetylcysteine Potentiates Inhibition of Platelet Aggregation by Nitroglycerin”, Journal of Clinical Investigation, 76: 703-708, 1985.
Kurz et al. “Nitroglycerin Metabolism in Vascular Tissue: Role of Glutathione S-Transferases and Relationship Between NO and NO2-Formation”, Biochemical Journal, 292: 545-550, 1993.
Münzel “Does Nitroglycerin Therapy Hit the Endothelium?”, Journal of the American College of Cardiology, 38: 1102-1105, 2001.
Schönafinger “Heterocyclic NO Prodrugs”, Il Farmaco, 54: 316-320, 1999.
Silberg et al. “Thiazoles. XI. Synthesis and Behavior of Some New Halogenated Formylthiazoles”, Studia Universitatis Babes-Bolyai, chemia, 10(1): 27-31, 1965, Caplus An 1965:488847.

Affiliated with

Also associated with

Rating

Thiazole-based nitric oxide donors having alkyl... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thiazole-based nitric oxide donors having alkyl..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazole-based nitric oxide donors having alkyl... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4118351